×
Back to Agenda
Session 5, Part 1: Tech Innovation for Life Sciences
Session Chair(s)
Scott Askin, MSC
Global Program Regulatory Director, Novartis Pharma AG, Switzerland
Michael Forstner, PHD, MPH, MSC
Managing Director, Head of Pharmacoepidemiology Practice, Mesa Laubela-Consulting, Switzerland
Session 5, Part 1: Tech Innovation for Life Sciences
Speaker(s)
Greg Davis
COO, Analytics4Life (A4L), United States
AI Application for Early Diagnosis in Rare Disease
Have an account?